Protective Effects of Remimazolam on Cerebral Ischemia/Reperfusion Injury in Rats by Inhibiting of NLRP3 Inflammasome-Dependent Pyroptosis

INTRODUCTION: Remimazolam is a novel benzodiazepine γ-aminobutyric acid A (GABAa) receptor agonist used for sedation and the induction as well as maintenance of general anesthesia. Previous research proved that anesthetic agents acting on GABAa receptor, such as thiopentone, propofol and midazolam,...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Min, Chen, Jing, Liu, Tianxiao, Dai, Weixin, Zhou, Zhan, Chen, Lifei, Xie, Yubo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863189/
https://www.ncbi.nlm.nih.gov/pubmed/35210755
http://dx.doi.org/10.2147/DDDT.S344240

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863189/
https://www.ncbi.nlm.nih.gov/pubmed/35210755
http://dx.doi.org/10.2147/DDDT.S344240

Ejemplares similares